Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Heisoog Kim
Observed name:
Kim, Heisoog
Institutions:
Massachusetts General Hospital,
Athinoula A. Martinos Center for Biomedical Imaging
Observed institutions:
Oslo University Hospital,
Harvard University,
Massachusetts General Hospital,
Dana-Farber Cancer Institute,
Athinoula A. Martinos Center for Biomedical Imaging,
National Cancer Institute,
Massachusetts Institute of Technology
show all 7
OpenAlex ID:
A5043584792
Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2011
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
·
Cancer Research
·
297
Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
2011
·
Heisoog Kim
, Ciprian Catana
, et al.
·
Cancer Research
·
49
PDF
Development of integrated imaging techniques for investigating biomarkers in glioblastoma
2011
·
Heisoog Kim
·
DSpace@MIT (Massachusetts Institute of Technology)
·
1
Supplementary Figure 4 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
PDF
Data from Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
2023
·
Heisoog Kim
, Ciprian Catana
, et al.
Supplementary Figure 6 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
PDF
Supplementary Appendix, Table 1, Figure Legends 1-4 from Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
2023
·
Heisoog Kim
, Ciprian Catana
, et al.
PDF
Supplementary Figure 7 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
Supplementary Figure 5 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
Supplementary Figure 1 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
Supplementary Figure 2 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
Supplementary Figure 6 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
Supplementary Figure 4 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
Supplementary Methods, Figures 1-4 from Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
2023
·
Heisoog Kim
, Ciprian Catana
, et al.
PDF
Supplementary Appendix, Table 1, Figure Legends 1-4 from Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
2023
·
Heisoog Kim
, Ciprian Catana
, et al.
Supplementary Table 1, Figure Legends 1-7 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
Supplementary Figure 3 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
Supplementary Figure 1 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
PDF
Supplementary Figure 2 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
PDF
Supplementary Figure 7 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
PDF
Supplementary Figure 5 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
PDF
Supplementary Figure 3 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
PDF
Supplementary Methods, Figures 1-4 from Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
2023
·
Heisoog Kim
, Ciprian Catana
, et al.
Supplementary Table 1, Figure Legends 1-7 from Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
2023
·
A. Gregory Sorensen
, Kyrre E. Emblem
, et al.
PDF
Data from Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
2023
·
Heisoog Kim
, Ciprian Catana
, et al.
Show more works
View as search
Works count:
28
Citation count:
347
H-index:
2
I10-index:
2
Year
Topic
Type